Literature DB >> 6234105

New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMR.

M C Malet-Martino, R Martino, A Lopez, J P Béteille, M Bon, J Bernadou, J P Armand.   

Abstract

The metabolism of 5'-deoxy-5-fluorouridine (5'dFUrd), an antitumor fluoropyrimidine, has been investigated in human biofluids (blood, plasma, urine) using a new method: fluorine-19 NMR spectrometry. This method allows direct study of the biological sample and simultaneous identification of all the fluorinated metabolites. In the blood of a patient treated with 5'dFUrd during a 6-h continuous perfusion, we observed unmetabolized 5'dFUrd, 5-fluorouracil, 5,6-dihydrofluorouracil, and another metabolite which has not previously been reported alpha-fluoro-beta-alanine. The two major metabolites in urine are unmetabolized 5'dFUrd and alpha-fluoro-beta-alanine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234105     DOI: 10.1007/bf00401443

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14.

Authors:  K L MUKHERJEE; C HEIDELBERGER
Journal:  J Biol Chem       Date:  1960-02       Impact factor: 5.157

2.  Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.

Authors:  R D Armstrong; R B Diasio
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

Review 3.  The pharmacology of the fluoropyrimidines.

Authors:  C E Myers
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

4.  Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography.

Authors:  J P Sommadossi; D A Gewirtz; R B Diasio; C Aubert; J P Cano; I D Goldman
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

5.  Determination of a novel fluoropyrimidine, 5'-deoxy-5-fluorouridine, in plasma by high-performance liquid chromatography.

Authors:  J P Sommadossi; J P Cano
Journal:  J Chromatogr       Date:  1981-10-09

6.  Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.

Authors:  R D Armstrong; R B Diasio
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

7.  5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.

Authors:  R D Armstrong; E Cadman
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

8.  Quantitative analysis of 5-fluorouracil and 5,6-dihydrofluorouracil in plasma by gas chromatography mass spectrometry.

Authors:  C Aubert; J P Sommadossi; P Coassolo; J P Cano; J P Rigault
Journal:  Biomed Mass Spectrom       Date:  1982-08

9.  Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats.

Authors:  S Suzuki; Y Hongu; H Fukazawa; S Ichihara; H Shimizu
Journal:  Gan       Date:  1980-04

10.  Comparative studies on the immunosuppressive effect among 5'-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil.

Authors:  Y Ohta; K Sueki; K Kitta; K Takemoto; H Ishitsuka; Y Yagi
Journal:  Gan       Date:  1980-04
View more
  4 in total

Review 1.  Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

Authors:  P Chrisp; D McTavish
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

2.  Noninvasive and quantitative 19F nuclear magnetic resonance study of flucytosine metabolism in Candida strains.

Authors:  J P Vialaneix; N Chouini; M C Malet-Martino; R Martino; G Michel; J P Lepargneur
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma.

Authors:  M C Malet-Martino; F Faure; J P Vialaneix; C Palevody; E Hollande; R Martino
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Metabolite Profiling in Anticancer Drug Development: A Systematic Review.

Authors:  Nadda Muhamad; Kesara Na-Bangchang
Journal:  Drug Des Devel Ther       Date:  2020-04-09       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.